Signs and Symptoms: Pain Signs and Symptoms Procedures for purposes other than remedying health state
Conditions
Interventions
A blinded member of the team will assess the pain at 2,4 and hours after the operation. Length of hospital stay is also recorded.
The data analysis will take place at Countess of Chester Hospital (CO
Sponsors
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients undergoing breast augmentation 2. For correction of congenital anomaly or asymmetry. This group is usually young population, so usually not associated with co-morbid conditions which might complicate result.
Exclusion criteria
Exclusion criteria: 1. Patients undergoing augmentation following mastectomy or as part of other reconstruction 2. Patients with multiple co-morbidity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is bupivacaine superior than placebo in pain control following breast augmentation? | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Does bupivacaine reduce opiate requirement? 2. Does it reduce hospital stay? 3. Does it reduce the incidence of opiate related adverse effects? | — |
Countries
United Kingdom
Outcome results
None listed